In SLE, multiple pathologic cytokines—such as type I interferons (IFNs), interleukin-6 (IL-6), IL-15, IL-2, IL-17, and IL-23—utilize JAK/STAT signaling. This evidence concerns the gene IL2 and systemic lupus erythematosus.